Major insurers like MetLife and Prudential, alongside insurtech firms such as Betterment and Wealthfront, leverage AI-driven platforms, aging-clock biotech, and age-friendly robotics to optimize retirement planning amid extended healthspans.
Key points
- MetLife’s U.S. annuities market reaches $430 billion with FIAs and RILAs offering market-linked growth and downside protection.
- Chronomics and Insilico Medicine deploy DNA methylation aging clocks to refine underwriting and predict individual healthspan trajectories.
- Fanuc and ABB automate labor with robotics while platforms like Coursera enable flexible 'unretirement,' addressing labor shortages in aging markets.
Why it matters: Integrating AI, biotech, and robotics into financial services unlocks scalable, personalized solutions for global aging, reshaping pension models and fueling the $70T longevity economy.
Q&A
- What is the longevity economy?
- How do AI-driven retirement planning platforms work?
- What are biological aging clocks?
- Why are annuities linked to longevity?
- How do age-friendly labor solutions address workforce aging?